TipRanks
Lineage Cell Therapeutics, Inc. (DE:BT3)
FRANKFURT:BT3
Germany Market
BT3
Lineage Therap
RESEARCH TOOLSreports

Lineage Therap (BT3) Balance Sheet

1 Followers

Lineage Therap Balance Sheet

Lineage Therap's total assets for Q2 2026 were $106.22M, a decrease of -3.02% from the previous quarter. DE:BT3 total liabilities were $46.42M for the fiscal quarter, a -18.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 112.58M$ 113.22M$ 101.02M$ 123.66M$ 174.54M
Total Liabilities
$ 69.24M$ 36.21M$ 39.00M$ 51.73M$ 83.65M
Total Equity Gross Minority
$ 43.35M$ 77.01M$ 62.02M$ 71.94M$ 90.90M
Other Metrics
Currency in USD

Lineage Therap Debt to Assets